HBK Investments’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-15,867
Closed -$430K 925
2017
Q2
$430K Buy
+15,867
New +$430K ﹤0.01% 684